Your browser doesn't support javascript.
loading
An IgG-based bispecific antibody for improved dual targeting in PSMA-positive cancer.
Zekri, Latifa; Vogt, Fabian; Osburg, Lukas; Müller, Stefanie; Kauer, Joseph; Manz, Timo; Pflügler, Martin; Maurer, Andreas; Heitmann, Jonas S; Hagelstein, Ilona; Märklin, Melanie; Hörner, Sebastian; Todenhöfer, Tilmann; Calaminus, Carsten; Stenzl, Arnulf; Pichler, Bernd; la Fougère, Christian; Schneider, Marc A; Rammensee, Hans-Georg; Zender, Lars; Sipos, Bence; Salih, Helmut R; Jung, Gundram.
Afiliación
  • Zekri L; Department of Immunology, Institute for Cell Biology, Eberhard Karls University Tuebingen, German Cancer Consortium (DKTK), Partner Site Tuebingen, Tuebingen, Germany.
  • Vogt F; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tuebingen, Tuebingen, Germany.
  • Osburg L; DFG Cluster of Excellence 2180 "Image-guided and Functional Instructed Tumor Therapy" (IFIT), Eberhard Karls University Tuebingen, Tuebingen, Germany.
  • Müller S; Department of Immunology, Institute for Cell Biology, Eberhard Karls University Tuebingen, German Cancer Consortium (DKTK), Partner Site Tuebingen, Tuebingen, Germany.
  • Kauer J; Department of Immunology, Institute for Cell Biology, Eberhard Karls University Tuebingen, German Cancer Consortium (DKTK), Partner Site Tuebingen, Tuebingen, Germany.
  • Manz T; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tuebingen, Tuebingen, Germany.
  • Pflügler M; DFG Cluster of Excellence 2180 "Image-guided and Functional Instructed Tumor Therapy" (IFIT), Eberhard Karls University Tuebingen, Tuebingen, Germany.
  • Maurer A; Department of Immunology, Institute for Cell Biology, Eberhard Karls University Tuebingen, German Cancer Consortium (DKTK), Partner Site Tuebingen, Tuebingen, Germany.
  • Heitmann JS; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tuebingen, Tuebingen, Germany.
  • Hagelstein I; DFG Cluster of Excellence 2180 "Image-guided and Functional Instructed Tumor Therapy" (IFIT), Eberhard Karls University Tuebingen, Tuebingen, Germany.
  • Märklin M; Department of Immunology, Institute for Cell Biology, Eberhard Karls University Tuebingen, German Cancer Consortium (DKTK), Partner Site Tuebingen, Tuebingen, Germany.
  • Hörner S; Department of Immunology, Institute for Cell Biology, Eberhard Karls University Tuebingen, German Cancer Consortium (DKTK), Partner Site Tuebingen, Tuebingen, Germany.
  • Todenhöfer T; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tuebingen, Tuebingen, Germany.
  • Calaminus C; DFG Cluster of Excellence 2180 "Image-guided and Functional Instructed Tumor Therapy" (IFIT), Eberhard Karls University Tuebingen, Tuebingen, Germany.
  • Stenzl A; Department for Preclinical Imaging and Radiopharmacy, Werner Siemens Imaging Center, Eberhard Karls University Tuebingen, Tuebingen, Germany.
  • Pichler B; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tuebingen, Tuebingen, Germany.
  • la Fougère C; DFG Cluster of Excellence 2180 "Image-guided and Functional Instructed Tumor Therapy" (IFIT), Eberhard Karls University Tuebingen, Tuebingen, Germany.
  • Schneider MA; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tuebingen, Tuebingen, Germany.
  • Rammensee HG; DFG Cluster of Excellence 2180 "Image-guided and Functional Instructed Tumor Therapy" (IFIT), Eberhard Karls University Tuebingen, Tuebingen, Germany.
  • Zender L; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tuebingen, Tuebingen, Germany.
  • Sipos B; DFG Cluster of Excellence 2180 "Image-guided and Functional Instructed Tumor Therapy" (IFIT), Eberhard Karls University Tuebingen, Tuebingen, Germany.
  • Salih HR; Department of Immunology, Institute for Cell Biology, Eberhard Karls University Tuebingen, German Cancer Consortium (DKTK), Partner Site Tuebingen, Tuebingen, Germany.
  • Jung G; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany.
EMBO Mol Med ; 13(2): e11902, 2021 02 05.
Article en En | MEDLINE | ID: mdl-33372710
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Anticuerpos Biespecíficos Límite: Animals / Humans / Male Idioma: En Revista: EMBO Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2021 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Anticuerpos Biespecíficos Límite: Animals / Humans / Male Idioma: En Revista: EMBO Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2021 Tipo del documento: Article País de afiliación: Alemania